Nuclear localization of activated STAT6 and STAT3 in epidermis of prurigo nodularis

British Journal of Dermatology

Volumn 165, Issue 5, 2011, Pages 990-996

  Fukushi, S ^a   Yamasaki, K ^a   Aiba, S ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HLA DR ANTIGEN; HYALURONIC ACID; HYALURONIC ACID BINDING PROTEIN; INTERLEUKIN 13; INTERLEUKIN 4; STAT1 PROTEIN; STAT3 PROTEIN; STAT6 PROTEIN; HERMES ANTIGEN; STAT1 PROTEIN, HUMAN; STAT3 PROTEIN, HUMAN;

ANTIGEN RETRIEVAL; ARTICLE; ATOPIC DERMATITIS; BIOACCUMULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPIDERMIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LICHEN PLANUS; MAJOR CLINICAL STUDY; NEURODERMATITIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PSORIASIS; SKIN BIOPSY; SKIN DEFECT; SKIN INFLAMMATION; TH1 CELL; TH2 CELL; CHEMISTRY; METABOLISM; NUCLEOLUS; PHOSPHORYLATION; PHYSIOLOGY; PRURIGO;

ANTIGENS, CD44; CELL NUCLEOLUS; CYTOKINES; EPIDERMIS; HLA-DR ANTIGENS; HUMANS; HYALURONIC ACID; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; INTERLEUKIN-13; INTERLEUKIN-4; PHOSPHORYLATION; PRURIGO; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; STAT6 TRANSCRIPTION FACTOR; TH1 CELLS; TH2 CELLS;

EID: 84856366908     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10498.x     Document Type: Article

References (29)

1. Lee MR, Shumack S. Prurigo nodularis: a review. Australas J Dermatol 2005; 46:211-18.
2. Agnello D, Lankford CS, Bream J et al. Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights. J Clin Immunol 2003; 23:147-61. (Pubitemid 36522792)
3. Chen Z, O'Shea JJ. Regulation of IL-17 production in human lymphocytes. Cytokine 2008; 41:71-8.
4. Rawlings JS, Rosler KM, Harrison DA. The JAK/STAT signaling pathway. J Cell Sci 2004; 117:1281-3. (Pubitemid 38559804)
5. Adamson AS, Collins K, Laurence A et al. The Current STATus of lymphocyte signaling: new roles for old players. Curr Opin Immunol 2009; 21:161-6.
6. Schindler C, Levy DE, Decker T. JAK-STAT signaling: from interferons to cytokines. J Biol Chem 2007; 282:20059-63. (Pubitemid 47099977)
7. Kotenko SV, Gallagher G, Baurin VV et al. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 2003; 4:69-77. (Pubitemid 36109115)
8. Takeda A, Hamano S, Yamanaka A et al. Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J Immunol 2003; 170:4886-90. (Pubitemid 36554716)
9. Sano S, Chan KS, DiGiovanni J. Impact of Stat3 activation upon skin biology: a dichotomy of its role between homeostasis and diseases. J Dermatol Sci 2008; 50:1-14. (Pubitemid 351249893)
10. Griffiths CE, Voorhees JJ, Nickoloff BJ. Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma inter-feron and tumor necrosis factor. J Am Acad Dermatol 1989; 20:617-29. (Pubitemid 19091260)
11. Volc-Platzer B, Leibl H, Luger T et al. Human epidermal cells synthesize HLA-DR alloantigens in vitro upon stimulation with gamma-interferon. J Invest Dermatol 1985; 85:16-19. (Pubitemid 15069706)
12. Wittmann M, Zeitvogel J, Wang D et al. IL-27 is expressed in chronic human eczematous skin lesions and stimulates human keratinocytes. J Allergy Clin Immunol 2009; 124:81-9.
13. Ohtani T, Memezawa A, Okuyama R et al. Increased hyaluronan production and decreased E-cadherin expression by cytokine-stim-ulated keratinocytes lead to spongiosis formation. J Invest Dermatol 2009; 129:1412-20.
14. Lowes MA, Kikuchi T, Fuentes-Duculan J et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 2008; 128:1207-11. (Pubitemid 351543220)
15. Gadina M, Hilton D, Johnston JA et al. Signaling by type I and II cytokine receptors: ten years after. Curr Opin Immunol 2001; 13:363-73. (Pubitemid 32537710)
16. Boniface K, Bernard FX, Garcia M et al. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol 2005; 174:3695-702. (Pubitemid 40354080)
17. Bieber T. Atopic dermatitis. N Engl J Med 2008; 358:1483-94.
18. Sano S, Chan KS, Carbajal S et al. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 2005; 11:43-9. (Pubitemid 40215836)
19. Bilsborough J, Leung DY, Maurer M et al. IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. J Allergy Clin Immunol 2006; 117:418-25. (Pubitemid 43190155)
20. Sonkoly E, Muller A, Lauerma AI et al. IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 2006; 117:411-17. (Pubitemid 43192023)
21. Neis MM, Peters B, Dreuw A et al. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis. J Allergy Clin Immunol 2006; 118:930-7. (Pubitemid 44498762)
22. Tanaka M, Aiba S, Matsumura N et al. Prurigo nodularis consists of two distinct forms: early-onset atopic and late-onset non-atopic. Dermatology 1995; 190:269-76.
23. Hamid Q, Boguniewicz M, Leung DY. Differential in situ cytokine gene expression in acute vs. chronic atopic dermatitis. J Clin Invest 1994; 94:870-6. (Pubitemid 24251022)
24. Sano S, Itami S, Takeda K et al. Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis. EMBO J 1999; 18:4657-68. (Pubitemid 29415520)
25. Wolk K, Haugen HS, Xu W et al. IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not. J Mol Med 2009; 87:523-36.
26. Zheng Y, Danilenko DM, Valdez P et al. Interleukin-22, a T(H) 17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007; 445:648-51. (Pubitemid 46232884)
27. Ma HL, Liang S, Li J et al. IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest 2008; 118:597-607. (Pubitemid 351206549)
28. Nograles KE, Zaba LC, Shemer A et al. IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J Allergy Clin Immunol 2009; 123:1244-52.e2.
29. Dillon SR, Sprecher C, Hammond A et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 2004; 5:752-60. (Pubitemid 39023308)